Anthropic has released Claude Fable 5.2 and Claude Mythos 5.2, its most capable models to date. They share one set of weights. The difference is the guardrails: Fable carries classifiers that refuse high-risk cybersecurity and most research biology requests, which is what allows the company to sell it to anyone. Mythos removes those blocks and is limited to organisations that pass Anthropic's cyber and life-sciences verification programmes.
One model, two levels of access
The split follows a regulatory scare. Washington restricted the previous Fable and Mythos models in June; Fable returned after Anthropic added the classifiers, and Mythos came back only for trusted partners. The company now says it is widening Mythos access to more firms in the United States and abroad.
Both models take a 1 million token context window and up to 128,000 tokens of output, with a knowledge cutoff of June 2026. They are hosted only — through Anthropic's own API, AWS, Google Cloud and Microsoft Azure — and no weights are published.
Benchmarks and price
On the numbers Anthropic published, Fable 5.2 scores 74.6% on Terminal Bench Science, up from 52.6% for the 5.1 version and ahead of OpenAI's GPT-6 Astra at 68.1%. It reaches 74.2% on Humanity's Last Exam, 49.1% on FrontierCode 2.0 and 64.9% on RoboDojo Sim, more than double Astra's 29.8%. It trails Gemini 4 Carbon on AutomationBench, 51.4% against 53.9%. All of these figures are self-reported.
Pricing is $8 per million input tokens and $40 per million output tokens, below the previous generation, with a fast mode at double the rate. Anthropic says Fable 5.2 refuses about 55% fewer requests than its predecessor.
What it means for customers
The company is not pitching Fable as a daily driver. Its own guidance tells most coding and knowledge workers to start with Claude Opus 5.5 and treat Fable as an adviser for the hardest problems — an unusual bit of positioning from a vendor that usually wants the newest model used everywhere.
The timing matters as much as the specs. Anthropic is near a stock listing that could happen this month, and the pitch to public investors is that frontier capability can be sold at falling prices without giving away the tools that regulators worry about.